ATE230024T1 - Entwicklung von dns-sonden und immunologischen reagenzien von menschlichen tumor-assoziierten antigenen - Google Patents

Entwicklung von dns-sonden und immunologischen reagenzien von menschlichen tumor-assoziierten antigenen

Info

Publication number
ATE230024T1
ATE230024T1 AT92909591T AT92909591T ATE230024T1 AT E230024 T1 ATE230024 T1 AT E230024T1 AT 92909591 T AT92909591 T AT 92909591T AT 92909591 T AT92909591 T AT 92909591T AT E230024 T1 ATE230024 T1 AT E230024T1
Authority
AT
Austria
Prior art keywords
development
human tumor
dna probe
associated antigens
immunological reagents
Prior art date
Application number
AT92909591T
Other languages
English (en)
Inventor
Paul B Fisher
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Application granted granted Critical
Publication of ATE230024T1 publication Critical patent/ATE230024T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT92909591T 1990-10-25 1991-10-25 Entwicklung von dns-sonden und immunologischen reagenzien von menschlichen tumor-assoziierten antigenen ATE230024T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60380490A 1990-10-25 1990-10-25
PCT/US1991/007912 WO1992008131A1 (en) 1990-10-25 1991-10-25 Development of dna probes and immunological reagents of human tumor associated antigens

Publications (1)

Publication Number Publication Date
ATE230024T1 true ATE230024T1 (de) 2003-01-15

Family

ID=24416995

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92909591T ATE230024T1 (de) 1990-10-25 1991-10-25 Entwicklung von dns-sonden und immunologischen reagenzien von menschlichen tumor-assoziierten antigenen

Country Status (8)

Country Link
US (2) US6184032B1 (de)
EP (1) EP0641385B1 (de)
JP (3) JP3256227B2 (de)
AT (1) ATE230024T1 (de)
AU (1) AU660001B2 (de)
CA (1) CA2094378A1 (de)
DE (1) DE69133185D1 (de)
WO (1) WO1992008131A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851764A (en) 1990-10-25 1998-12-22 The Trustees Of Columbia University In The City Of New York Human prostate tumor inducing gene-1 and uses thereof
US6979728B2 (en) * 1998-05-04 2005-12-27 Baylor College Of Medicine Articles of manufacture and methods for array based analysis of biological molecules
US6852291B1 (en) * 2000-10-11 2005-02-08 Innovadyne Technologies, Inc. Hybrid valve apparatus and method for fluid handling
JPWO2003010542A1 (ja) * 2001-07-25 2004-11-18 三菱ウェルファーマ株式会社 癌診断薬
US20030050266A1 (en) * 2001-09-07 2003-03-13 Fisher Paul B. Anti-tumor effects of prostate carcinoma tumor antigen-1
CA2468971A1 (en) * 2001-12-04 2003-06-12 Mitsubishi Pharma Corporation Method of activating protein
US7049121B2 (en) * 2001-12-20 2006-05-23 Applied Molecular Evolution Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
ATE377763T1 (de) * 2002-01-25 2007-11-15 Innovadyne Technologies Inc Kontaktloses verfahren zur verteilung geringer flüssigkeitsvolumen
US20060057147A1 (en) 2002-10-04 2006-03-16 Mitsubishi Pharma Corporation Antibody recognizing antibody
EP1574521B1 (de) * 2002-12-20 2009-05-20 Mitsubishi Tanabe Pharma Corporation Verfahren zum schutz von thiolgruppen in antikörpern

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634665A (en) * 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4935341A (en) * 1986-06-04 1990-06-19 Whitehead Institute For Biomedical Research Detection of point mutations in neu genes
US4535058A (en) * 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4631259A (en) * 1983-05-04 1986-12-23 Board Of Regents Of The University Of Michigan Transposon in cloning DNA
US4681840A (en) * 1984-01-18 1987-07-21 The United States Of America As Represented By The Secretary Of Commerce Deoxyribonucleic acid molecules useful as probes for detecting oncogenes incorporated into chromosomal DNA
US4871838A (en) * 1985-07-23 1989-10-03 The Board Of Rijks Universiteit Leiden Probes and methods for detecting activated ras oncogenes
JPS6319561A (ja) * 1986-07-11 1988-01-27 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
US4994558A (en) * 1986-12-24 1991-02-19 Eli Lilly And Company Immunoglobulin conjugates
US4914021A (en) * 1988-03-04 1990-04-03 New England Deaconess Hospital Corporation Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
JPH0797997B2 (ja) * 1988-04-28 1995-10-25 帝人株式会社 新規生理活性ポリペプチド
EP0346702A3 (de) * 1988-06-16 1991-08-28 Miles Inc. Transfizierte Zellinien, die isolierte Gene der karzinoembryonale Antigenfamilie exprimieren

Also Published As

Publication number Publication date
US6184032B1 (en) 2001-02-06
JP2002159293A (ja) 2002-06-04
JP3445586B2 (ja) 2003-09-08
EP0641385A4 (de) 1994-10-20
JP2001292767A (ja) 2001-10-23
WO1992008131A1 (en) 1992-05-14
US20010014474A1 (en) 2001-08-16
AU8931491A (en) 1992-05-26
AU660001B2 (en) 1995-06-08
DE69133185D1 (de) 2003-01-30
CA2094378A1 (en) 1992-04-26
JP3256227B2 (ja) 2002-02-12
EP0641385A1 (de) 1995-03-08
EP0641385B1 (de) 2002-12-18
JPH06505147A (ja) 1994-06-16
JP3376357B2 (ja) 2003-02-10

Similar Documents

Publication Publication Date Title
PT796280E (pt) Anticorpo monoclonal 3h1 anti-idiotipico dos murinos
BR8507031A (pt) Anticorpo monoclonal para um antigeno associado com tumor de carcinoma
ES2124209T3 (es) Anticuerpos monoclonales mejorados reactivos con caquectina.
JPS5786051A (en) Determination of antigen employing two or more monochronal antibodies
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
DE3482905D1 (de) Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs.
DE69133185D1 (de) Entwicklung von dns-sonden und immunologischen reagenzien von menschlichen tumor-assoziierten antigenen
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
GB9424631D0 (en) Modulating the immune response
IT7920592A0 (it) Determinazione di antigeni oppure di anticorpi.
DE3586216T2 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
DE3485712D1 (de) Monoklonale antikoerper gegen menschliche nierenkrebsantigene und verfahren.
IE792390L (en) Hepatitis be antigen.
DK21586A (da) Antigener og antistoffer samt praeparater indeholdende disse
AU6873587A (en) Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
ATE122723T1 (de) Retinoblastoma-genprodukt-antikörper und deren verwendungen.
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DK354288D0 (da) Kimaert antistof med specificitet over for humant tumorantigen
JPS57156560A (en) Determination of antigen or antibody
IT8119547A0 (it) Procedimento di conversione e di separazione di cariche idrocarbonate contenenti degli asfalteni.
IL60664A0 (en) Monoclonal antibodies and assay for the detection of breast cancer
ZW4783A1 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer
IT8221786V0 (it) Dispositivo scrivente particolarmente per la compilazione di schedine e simili.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties